ClinCalc Pro
Menu
Dopamine Agonist — Transdermal Patch (Parkinson's / RLS) Pregnancy: Avoid — limited data

Rotigotine

Brand names: Neupro

Adult dose

Dose: Parkinson's (early): start 2 mg/24h, titrate weekly by 2 mg/24h to max 8 mg/24h; Parkinson's (advanced): max 16 mg/24h; RLS: 1–3 mg/24h
Route: Transdermal patch (apply once daily, rotate sites)
Frequency: Once daily (change patch every 24 hours)
Max: 16 mg/24h (Parkinson's); 3 mg/24h (RLS)
Only transdermal dopamine agonist — provides continuous drug delivery avoiding peaks and troughs associated with oral agents. Particularly useful when oral route unavailable (nil by mouth, dysphagia). Rotate patch sites — abdomen, thigh, hip, flank, upper arm, shoulder.

Paediatric dose

Route:
Seek specialist opinion — not licensed in children.

Dose adjustments

Renal

No dose adjustment required.

Hepatic

Caution in severe hepatic impairment.

Clinical pearls

  • CRITICAL: remove patch before MRI — aluminium backing causes burns. The patient must be reminded at every MRI appointment.
  • ICD screening at every visit — same risks as oral dopamine agonists (QUIP questionnaire)
  • Continuous delivery advantage: avoids pulsatile dopamine stimulation — theoretically reduces dyskinesia development. Useful in patients with significant wearing-off on oral regimens.

Contraindications

  • MRI or cardioversion — remove patch before procedure (contains aluminium in backing layer)
  • Hypersensitivity to rotigotine

Side effects

  • Application site reactions (erythema, pruritus, oedema)
  • Impulse control disorders (ICD — gambling, hypersexuality)
  • Somnolence and sudden sleep onset
  • Nausea
  • Hallucinations
  • Peripheral oedema

Interactions

  • Antipsychotics (dopamine antagonism)
  • Metoclopramide (dopamine antagonism)
  • Other dopaminergic agents (additive effects)

Monitoring

  • ICD screening (QUIP)
  • Application site rotation and skin reactions
  • Blood pressure (postural)
  • Sleep assessment

Reference: BNFc; BNF 90; NICE NG71 (Parkinson's Disease); MHRA ICD Warning. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.